MYCAPSSA (Octreotide)

Octreotide · Chiasma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MYCAPSSA (Octreotide), covering 2015-12-01 to 2015-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly [Phase 3]